Springer Healthcare IME
Springer Healthcare Independent Medical Education (IME) creates expert-led educational programs that build upon the latest research and professional practice guidelines. Our suite of educational programs are designed to bring about meaningful change in physician behavior by increasing diagnostic ability, optimizing treatment regimens, and thereby contributing to improved patient outcomes.
Springer Healthcare IME
Targeted Therapy for NTRK Fusion-Positive Cancers
By
Springer Healthcare IME
FEATURING
Alex Drilon
By
Springer Healthcare IME
FEATURING
Alex Drilon
In this video, Alexander Drilon summarises the targeted therapy options for NTRK fusion-positive non-small cell lung cancer (NSCLC).
View our CME-accredited clinical pathway tool, designed to guide you through the best practices for detection and treatment of NTRK fusions in NSCLC at https://nsclc-biomarkers-ime.springermedicine.com/courses/detecting-and-targeting-ntrk-fusions-in-nsclc/
This tool is summarised into a free, downloadable practice aid available for use directly in your clinical practice. Complete the short evaluation form available on the page to collect your CME credits.
This independent medical education program is supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc.
View our CME-accredited clinical pathway tool, designed to guide you through the best practices for detection and treatment of NTRK fusions in NSCLC at https://nsclc-biomarkers-ime.springermedicine.com/courses/detecting-and-targeting-ntrk-fusions-in-nsclc/
This tool is summarised into a free, downloadable practice aid available for use directly in your clinical practice. Complete the short evaluation form available on the page to collect your CME credits.
This independent medical education program is supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc.
Comments 0
Login to view comments.
Click here to Login
